143 related articles for article (PubMed ID: 28545202)
1. Memantine inhibits degradation of the articular cartilage extracellular matrix induced by advanced glycation end products (AGEs).
Zhao J; Yu Y; Wu Z; Wang L; Li W
Biomed Pharmacother; 2017 Jul; 91():1193-1198. PubMed ID: 28545202
[TBL] [Abstract][Full Text] [Related]
2. The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes.
Li H; Chen J; Li B; Fang X
Chem Biol Interact; 2020 May; 322():108968. PubMed ID: 32004530
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin prevents articular cartilage matrix destruction in human chondrocytes.
Liu J; Cao L; Gao X; Chen Z; Guo S; He Z; Qian Y; Yu Y; Wang G
Biomed Pharmacother; 2018 Feb; 98():651-655. PubMed ID: 29291551
[TBL] [Abstract][Full Text] [Related]
4. Agonism of GPR39 displays protective effects against advanced glycation end-product (AGE)-induced degradation of extracellular matrix in human SW1353 cells.
Shan W; Qi J; Li C; Nie X
Arch Biochem Biophys; 2019 Nov; 677():108164. PubMed ID: 31678046
[TBL] [Abstract][Full Text] [Related]
5. Lixisenatide attenuates advanced glycation end products (AGEs)-induced degradation of extracellular matrix in human primary chondrocytes.
Li X; Jia F; Zhu Z; Huang L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1256-1264. PubMed ID: 30942623
[TBL] [Abstract][Full Text] [Related]
6. Oxytocin prevents cartilage matrix destruction via regulating matrix metalloproteinases.
Wu Y; Wu T; Xu B; Xu X; Chen H; Li X
Biochem Biophys Res Commun; 2017 May; 486(3):601-606. PubMed ID: 28238786
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products cause collagen II reduction by activating Janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytes.
Huang CY; Lai KY; Hung LF; Wu WL; Liu FC; Ho LJ
Rheumatology (Oxford); 2011 Aug; 50(8):1379-89. PubMed ID: 21482542
[TBL] [Abstract][Full Text] [Related]
8. Salicin inhibits AGE-induced degradation of type II collagen and aggrecan in human SW1353 chondrocytes: therapeutic potential in osteoarthritis.
Gao F; Zhang S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1043-1049. PubMed ID: 30942091
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib prevents the expression of MMP-13 and the degradation of collagen type 2 in human chondrocytes.
Hu W; Zhang W; Li F; Guo F; Chen A
Biochem Biophys Res Commun; 2014 Sep; 452(3):526-30. PubMed ID: 25172660
[TBL] [Abstract][Full Text] [Related]
10. The protective effects of Donepezil (DP) against cartilage matrix destruction induced by TNF-α.
Zhang D; Zhou Y
Biochem Biophys Res Commun; 2014 Nov; 454(1):115-8. PubMed ID: 25450366
[TBL] [Abstract][Full Text] [Related]
11. Activation of GPR40 Suppresses AGE-Induced Reduction of Type II Collagen and Aggrecan in Human SW1353 Chondrocytes.
Gu J; Lin H; Zhang Y; Xu T; Wang T; Xue X; Zhang W; Liu H
Drug Des Devel Ther; 2020; 14():2371-2379. PubMed ID: 32606604
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone inhibits advanced glycation end product-induced matrix metalloproteinases and apoptosis by suppressing the activation of MAPK and NF-κB.
Zhang HB; Zhang Y; Chen C; Li YQ; Ma C; Wang ZJ
Apoptosis; 2016 Oct; 21(10):1082-93. PubMed ID: 27515513
[TBL] [Abstract][Full Text] [Related]
13. Vildagliptin reduced extracellular matrix degradation in human primary chondrocytes.
Wang Z; Xu M; Bai J; Ge G; Guo X; Yu B; Xiao L; Geng D; Hao Y
Eur J Pharmacol; 2019 Feb; 844():49-55. PubMed ID: 30452909
[TBL] [Abstract][Full Text] [Related]
14. Glatiramer acetate inhibits degradation of collagen II by suppressing the activity of interferon regulatory factor-1.
Lu H; Zeng C; Zhao H; Lian L; Dai Y
Biochem Biophys Res Commun; 2014 Jun; 448(3):323-8. PubMed ID: 24657155
[TBL] [Abstract][Full Text] [Related]
15. Saxagliptin suppresses degradation of type II collagen and aggrecan in primary human chondrocytes: a therapeutic implication in osteoarthritis.
Hu N; Gong X; Yin S; Li Q; Chen H; Li Y; Li F; Qing L; Yang J; Zhu S; Wang J; Li J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3239-3245. PubMed ID: 31364869
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol prevents the degradation of collagen type II in human chondrocytes.
Wang W; Kang W; Tang Q; Yao G; Chen Y; Cheng B; Kong K
Biochem Biophys Res Commun; 2014 Aug; 451(3):352-5. PubMed ID: 25044117
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products induce peroxisome proliferator-activated receptor γ down-regulation-related inflammatory signals in human chondrocytes via Toll-like receptor-4 and receptor for advanced glycation end products.
Chen YJ; Sheu ML; Tsai KS; Yang RS; Liu SH
PLoS One; 2013; 8(6):e66611. PubMed ID: 23776688
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of periostin in human osteoarthritic cartilage and its potential role in matrix degradation via matrix metalloproteinase-13.
Attur M; Yang Q; Shimada K; Tachida Y; Nagase H; Mignatti P; Statman L; Palmer G; Kirsch T; Beier F; Abramson SB
FASEB J; 2015 Oct; 29(10):4107-21. PubMed ID: 26092928
[TBL] [Abstract][Full Text] [Related]
19. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
[TBL] [Abstract][Full Text] [Related]
20. Interferonregulatoryfactor-8(IRF-8) regulates the expression of matrix metalloproteinase-13 (MMP-13) in chondrocytes.
Yang Q; Ding W; Cao Y; Zhou Y; Ni S; Shi T; Fu W
Cell Stress Chaperones; 2018 May; 23(3):393-398. PubMed ID: 29247272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
